Molecule Information
      General Information of the Molecule (ID: Mol01009)
  
  | Name | Multidrug efflux pump Tap (TAP)
                                ,Mycobacterium fortuitum
                               | ||||
|---|---|---|---|---|---|
| Synonyms | Tetracycline-aminoglycoside resistance protein     Click to Show/Hide | ||||
| Molecule Type | Protein | ||||
| Gene Name | tap | ||||
| Sequence | MTNTKRGPLLLILFAALTAGAGNGITIVAFPWLVLQHNGSALDASIVAMAGTLPLLVATL IAGAAVDYLGRRRVSMISDLLSALSVAAVPVLALIFGVDAVNVAVLAVLAGLGAFFDPAG MTARETMLPEAAGRAGWTLDHANSVYEAVFNLGYIVGPGIGGLMIATLGGINTMWVTAGA FCCSILAISVLRLEGAGAPDRSVLTEAVLAGIVEGLRFVWYTPVLRTLAIVDLVATGLYM PMESVLFPKYFTDRNEPTELGWVLMALSIGGLLGALGYAVMSRYMSRRATMLTAVITLGV AMTVIAFLPPLPLILVLCAIVGFVYGPIAPIYNYVMQTTAPQHLRGRVVGVMGSLAYAAG PLGLILAGPLADAAGLHATFLALSLPMLLLGVVAVFLPRLRELDLASKP     Click to Show/Hide | ||||
| Function | Efflux pump that contributes to intrinsic antibiotic resistance. The pump uses the electrochemical gradient as a source of energy. Confers low-level resistance to tetracycline and to several aminoglycosides, including streptomycin, gentamicin, 2'-N-ethylnetilmicin and 6'-N-ethylnetilmicin.     Click to Show/Hide | ||||
| Uniprot ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
      Type(s) of Resistant Mechanism of This Molecule
  
  
      Drug Resistance Data Categorized by Drug
  
  Approved Drug(s)
      2 drug(s) in total
      
    | Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|  | ||||
| Disease Class: Bacterial infection | [1], [2] | |||
| Resistant Disease | Bacterial infection [ICD-11: 1A00-1C4Z] | |||
| Resistant Drug | Ofloxacin | |||
| Molecule Alteration | Expression | Up-regulation | ||
| Experimental Note | Identified from the Human Clinical Data | |||
| In Vitro Model | Mycobacterium tuberculosis H37Rv | 83332 | ||
| Mycobacterium tuberculosis ICC154 | 1773 | |||
| Experiment for Molecule Alteration | Whole genome sequence assay | |||
| Experiment for Drug Resistance | MIC assay | |||
| Mechanism Description | One mechanism proposed for drug resistance in Mycobacterium tuberculosis (MTB) is by efflux of the drugs by membrane located pumps.Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump,which confers resistance to Rifampin and Ofloxacin. | |||
| Disease Class: Bacterial infection | [1], [2] | |||
| Resistant Disease | Bacterial infection [ICD-11: 1A00-1C4Z] | |||
| Resistant Drug | Ofloxacin | |||
| Molecule Alteration | Expression | Up-regulation | ||
| Experimental Note | Identified from the Human Clinical Data | |||
| In Vitro Model | Mycobacterium tuberculosis H37Rv | 83332 | ||
| Mycobacterium tuberculosis ICC154 | 1773 | |||
| Experiment for Molecule Alteration | Whole genome sequence assay | |||
| Experiment for Drug Resistance | MIC assay | |||
| Mechanism Description | One mechanism proposed for drug resistance in Mycobacterium tuberculosis (MTB) is by efflux of the drugs by membrane located pumps.Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump,which confers resistance to Rifampin and Ofloxacin. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|  | ||||
| Disease Class: Mycobacterium fortuitum infection | [1], [2] | |||
| Resistant Disease | Mycobacterium fortuitum infection [ICD-11: 1B2Z.2] | |||
| Resistant Drug | Rifampin | |||
| Molecule Alteration | Expression | Up-regulation | ||
| Experimental Note | Identified from the Human Clinical Data | |||
| In Vitro Model | Mycobacterium tuberculosis H37Rv | 83332 | ||
| Mycobacterium tuberculosis ICC154 | 1773 | |||
| Experiment for Molecule Alteration | Whole genome sequence assay | |||
| Experiment for Drug Resistance | MIC assay | |||
| Mechanism Description | One mechanism proposed for drug resistance in Mycobacterium tuberculosis (MTB) is by efflux of the drugs by membrane located pumps.Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump,which confers resistance to Rifampin and Ofloxacin. | |||
      References
  
  visits since 2022
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.
